Fig. 4From: Safety and efficacy of bone marrow-derived cells therapy on cardiomyopathy: a meta-analysisForest plot of pooled left ventricular end-systolic volume (LVESV) with bone marrow-derived cell treatment compared with the control groupBack to article page